#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Indolent systemic mastocytosis Vernal keratoconjunctivitis Human papilloma virus immunisation Biotinidase deficiency Primary mediastinal large B-cell lymphoma Immunodeficiency Behcet's syndrome Burkitt's lymphoma refractory Chronic myelomonocytic leukaemia Retinitis pigmentosa Polycythaemia vera B-cell lymphoma recurrent Squamous cell carcinoma of the cervix Adrenogenital syndrome Congenital pseudarthrosis More trials…

    Learn about Rare Diseases

    Phenylketonuria – Trials in Disease Hereditary motor and sensory neuropathy – Life with Disease Choroid melanoma – Diagnostics Wolfram syndrome Alport’s syndrome – Basic Information Hepatic angiosarcoma – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Rhabdomyosarcoma – Diagnostics Malignant fibrous histiocytoma – Life with Disease Adrenogenital syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anastrozole TRV045 Resamirigene Bilparvovec Cetirizine Dihydrochloride Ilofotase Alfa Nusinersen Letetresgene Autoleucel Varnimcabtagene Autoleucel Calcium Levofolinate Ivabradine Gadoquatrane Acetylcysteine Amide Potassium MOLNUPIRAVIR Mk-1088 Amy109 Sodium Picosulfate Dexamethasone Heparin Calcium Leucine More therapies…

    Learn about Your Condition

    Pemphigus Immune-mediated enterocolitis Follicular lymphoma Acquired haemophilia Bladder cancer stage II Peripheral artery angioplasty Retinitis pigmentosa Niemann-Pick disease Short-bowel syndrome Muscle hypertrophy Takayasu's arteritis Gastrectomy Polycythaemia vera Pulmonary resection Agitation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Soft tissue sarcoma

  • Study on Tislelizumab for Cancer Patients with Molecular Residual Disease After Standard Treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tislelizumab
    • Sodium Chloride
    France

  • Comparison of Cyclophosphamide and Doxorubicin for Treatment of Advanced or Metastatic Soft Tissue Sarcoma in Patients Age 65 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Dexrazoxane Hydrochloride
    • Filgrastim
    • Cyclophosphamide
    France

  • Study of Trabectedin and Low-Dose Radiation Therapy for Adults and Young Adults with Advanced or Metastatic Soft Tissue and Bone Sarcomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chondrosarcoma
    • Sarcoma
    • Desmoplastic small round cell tumour
    Investigated Drugs:
    • Trabectedin
    • Irinotecan Hydrochloride Trihydrate
    Spain

  • Study on the Effectiveness of Doxorubicin, Ifosfamide, and Dacarbazine in High-Risk Soft Tissue Sarcoma Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dacarbazine Citrate
    • Ifosfamide
    • Doxorubicin
    France

  • Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Nephroblastoma
    • Rhabdoid tumour
    • Desmoplastic small round cell tumour
    Investigated Drugs:
    • 7-Ethyl-10-Hydroxycamptothecin
    Spain

  • Study of Selinexor and Gemcitabine for Patients with Advanced Soft-Tissue Sarcoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Gemcitabine
    • Selinexor
    Spain
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!